Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
41,59
USD
|
-0,60%
|
|
+2,24%
|
-17,79%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
8.497
|
7.906
|
4.297
|
5.365
|
7.258
|
6.066
|
-
|
-
|
Bedrijfswaarde
1 |
8.602
|
8.047
|
4.649
|
4.561
|
6.157
|
5.955
|
6.284
|
6.391
|
K/w-verhouding
|
29
x
|
-17,5
x
|
-152
x
|
-19,9
x
|
-19,8
x
|
-10,5
x
|
-12,4
x
|
-21,8
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
7,57
x
|
10,8
x
|
5,3
x
|
9,14
x
|
9,21
x
|
9,75
x
|
7,85
x
|
5,51
x
|
Bedrijfswaarde/omzet
|
7,66
x
|
11
x
|
5,74
x
|
7,77
x
|
7,81
x
|
9,57
x
|
8,13
x
|
5,8
x
|
Bedrijfswaarde/EBITDA
|
22,7
x
|
-50,7
x
|
35,6
x
|
-11,5
x
|
-18
x
|
-11,3
x
|
-11,9
x
|
-23,8
x
|
Bedrijfswaarde/FCF
|
27,3
x
|
10,4
x
|
247
x
|
-15,7
x
|
-18,6
x
|
-11,9
x
|
-13,4
x
|
-26,1
x
|
FCF Yield
|
3,66%
|
9,59%
|
0,41%
|
-6,36%
|
-5,38%
|
-8,39%
|
-7,44%
|
-3,82%
|
Price to Book
|
5,12
x
|
9,39
x
|
5,57
x
|
9,37
x
|
18,9
x
|
-115
x
|
-11,4
x
|
-9,76
x
|
Aantal aandelen (in duizenden)
|
140.663
|
139.823
|
141.210
|
142.050
|
143.472
|
145.846
|
-
|
-
|
Referentieprijs
2 |
60,41
|
56,54
|
30,43
|
37,77
|
50,59
|
41,59
|
41,59
|
41,59
|
Datum van publicatie
|
26/02/20
|
24/02/21
|
24/02/22
|
22/02/23
|
21/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.123
|
729
|
810
|
587
|
788
|
622,3
|
772,9
|
1.101
|
EBITDA
1 |
378,4
|
-158,7
|
130,5
|
-395,9
|
-342,7
|
-526,7
|
-528,3
|
-268
|
Bedrijfsresultaat (EBIT)
1 |
366
|
-172
|
-30
|
-411
|
-353
|
-578,4
|
-481,2
|
-280,4
|
Operationele Marge
|
32,59%
|
-23,59%
|
-3,7%
|
-70,02%
|
-44,8%
|
-92,94%
|
-62,25%
|
-25,47%
|
Resultaat voor belastingen (EBT)
1 |
347
|
-170
|
-30
|
-258
|
-334
|
-601,7
|
-526,6
|
-322,5
|
Nettowinst (verlies)
1 |
294
|
-451
|
-29
|
-270
|
-366
|
-573,3
|
-495,7
|
-285,2
|
Nettomarge
|
26,18%
|
-61,87%
|
-3,58%
|
-46%
|
-46,45%
|
-92,12%
|
-64,13%
|
-25,9%
|
WPA
2 |
2,080
|
-3,230
|
-0,2000
|
-1,900
|
-2,560
|
-3,974
|
-3,355
|
-1,909
|
Free Cash Flow
1 |
314,8
|
772
|
18,84
|
-290,1
|
-331,3
|
-499,5
|
-467,4
|
-244,4
|
FCF-marge
|
28,03%
|
105,9%
|
2,33%
|
-49,42%
|
-42,05%
|
-80,25%
|
-60,47%
|
-22,2%
|
Kasstroomconversie (ebitda)
|
83,19%
|
-
|
14,44%
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
107,08%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
26/02/20
|
24/02/21
|
24/02/22
|
22/02/23
|
21/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
133
|
440
|
142
|
134
|
160
|
152
|
131
|
188
|
144
|
325
|
138,6
|
144,5
|
164,7
|
173,8
|
143,2
|
EBITDA
1 |
-82,14
|
247,8
|
-53,8
|
-81,73
|
-55,34
|
-205
|
-111,4
|
-
|
-140,7
|
-3,456
|
-152,1
|
-155,2
|
-97,15
|
-104,3
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-86
|
221
|
-57
|
-86
|
-59
|
-208
|
-114
|
-91
|
-143
|
-6
|
-156,1
|
-158,9
|
-142,3
|
-147,9
|
-178
|
Operationele Marge
|
-64,66%
|
50,23%
|
-40,14%
|
-64,18%
|
-36,88%
|
-136,84%
|
-87,02%
|
-48,4%
|
-99,31%
|
-1,85%
|
-112,62%
|
-109,95%
|
-86,44%
|
-85,09%
|
-124,3%
|
Resultaat voor belastingen (EBT)
1 |
-84
|
225
|
-64
|
-103
|
-47
|
-44
|
-113
|
-77
|
-141
|
-3
|
-157,9
|
-163
|
-145,1
|
-145,5
|
-191,8
|
Nettowinst (verlies)
1 |
-82
|
225
|
-65
|
-105
|
-47
|
-52
|
-124
|
-85
|
-147
|
-9
|
-154,6
|
-159,5
|
-144,3
|
-145,5
|
-192,5
|
Nettomarge
|
-61,65%
|
51,14%
|
-45,77%
|
-78,36%
|
-29,38%
|
-34,21%
|
-94,66%
|
-45,21%
|
-102,08%
|
-2,77%
|
-111,57%
|
-110,39%
|
-87,65%
|
-83,75%
|
-134,4%
|
WPA
2 |
-0,5800
|
1,410
|
-0,4600
|
-0,7400
|
-0,3300
|
-0,3700
|
-0,8700
|
-0,6000
|
-1,030
|
-0,0600
|
-1,056
|
-1,054
|
-0,9811
|
-1,024
|
-1,307
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/11/21
|
24/02/22
|
4/05/22
|
9/08/22
|
9/11/22
|
22/02/23
|
3/05/23
|
9/08/23
|
2/11/23
|
21/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
104
|
141
|
352
|
-
|
-
|
-
|
218
|
325
|
Nettokaspositie
1 |
-
|
-
|
-
|
804
|
1.102
|
111
|
-
|
-
|
Hefboom (schuld/ebitda)
|
0,2755
x
|
-0,8912
x
|
2,697
x
|
-
|
-
|
-
|
-0,4131
x
|
-1,213
x
|
Free Cash Flow
1 |
315
|
772
|
18,8
|
-290
|
-331
|
-499
|
-467
|
-244
|
ROE (netto-inkomsten/eigen vermogen)
|
23,4%
|
-3,88%
|
-3,78%
|
-40,1%
|
-76,3%
|
-277%
|
-11,5%
|
-186%
|
ROA (netto-inkomsten/totale activa)
|
9,97%
|
-4,4%
|
-1,14%
|
-10,5%
|
-13,3%
|
-35,1%
|
-35%
|
-6,6%
|
Totale activa
1 |
2.949
|
10.245
|
2.536
|
2.575
|
2.760
|
1.633
|
1.418
|
4.321
|
Nettoactief per aandeel
2 |
11,80
|
6,020
|
5,470
|
4,030
|
2,680
|
-0,3600
|
-3,650
|
-4,260
|
Cashflow per aandeel
2 |
2,420
|
0,2600
|
0,2200
|
-1,930
|
-2,150
|
-2,490
|
-1,840
|
0,8500
|
Capex
1 |
30,9
|
35,1
|
12
|
15,7
|
23,8
|
23,7
|
27,9
|
29,7
|
Capex/omzet
|
2,75%
|
4,82%
|
1,48%
|
2,68%
|
3,02%
|
3,81%
|
3,6%
|
2,7%
|
Datum van publicatie
|
26/02/20
|
24/02/21
|
24/02/22
|
22/02/23
|
21/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
41,59
USD Gemiddelde koersdoel
58,13
USD Spread / Gemiddelde doel +39,77% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -17,79% | 6,07 mld. | | +1,51% | 42,75 mld. | | +49,22% | 41,61 mld. | | +8,57% | 41,34 mld. | | -12,36% | 26,59 mld. | | +8,92% | 25,49 mld. | | -25,13% | 18,12 mld. | | +29,17% | 12,24 mld. | | -3,12% | 11,76 mld. | | +6,35% | 11 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|